The Foundation
Data Acquisition & Sensors
Protecting the hardware designs, sensor placements, and wearable configurations that enable consistent, high-quality signal capture across different body types and gestational ages.
Nuvo’s category-defining platform is protected by a robust intellectual property portfolio designed to safeguard innovation end-to-end—from how data is captured and processed to how clinically meaningful insights are delivered. We don't just protect a device; we protect the entire pipeline that transforms raw signals into life-changing insights.

Instead of relying on narrow technical claims, Nuvo’s IP strategy creates durable barriers to entry by protecting how data is captured, processed, and transformed into clinical value.
Protecting the hardware designs, sensor placements, and wearable configurations that enable consistent, high-quality signal capture across different body types and gestational ages.
Proprietary methods for separating fetal heart signals from maternal noise and motion artifacts, ensuring clinical-grade data integrity in real-world environments.
Protecting the advanced algorithms and AI models that transform raw ECG and PCG data into actionable clinical assessments for fetal and maternal well-being

Nuvo is a pioneer in jointly analyzing multiple biophysical signals at scale. Our patents protect the fusion of electrical (ECG) and acoustic (PCG) data, allowing the system to compensate for motion and provide a coherent, validated view of pregnancy that single-signal technologies cannot replicate.

Because our platform enables continuous monitoring in real-world settings, it generates a growing repository of high-quality, longitudinal data. This data strengthens our AI models, which in turn improves clinical performance and reinforces adoption—a flywheel effect protected by our core IP.

Our IP strategy isn't just about protecting features; it’s about creating long-term strategic value. This supports competitive defense, partnership leverage for global collaborations, and clear ownership over an entirely new category of maternal health data.
Nuvo’s intellectual property strategy reflects our belief that pregnancy monitoring is entering a new era—one driven by continuous data, multimodal signals, and AI-powered insights. By protecting the foundational technologies that make this possible, we have created more than just a product advantage; we have built a durable, defensible platform for the future of maternal and fetal care.
Prevents replication of our end-to-end system
Enables global licensing and strategic collaborations
Demonstrates full control over our core technologies
Supports expansion into new clinical indications and insights
